Idiopathic cholesterol crystal embolism with atheroembolic renal disease and blue toes syndrome: A case report

BACKGROUND Cholesterol crystal embolization (CCE) is a multisystemic and fatal disease with multiple clinical manifestations; however, there are few cases of idiopathic CCE. Here we report a patient with idiopathic CCE accompanied by atheroembolic renal disease and blue toes who had a relatively good prognosis in the short-term due to early treatment with corticosteroids and statins. CASE SUMMARY A 76-year-old man complained of coldness, numbness and purple color change in his left foot for 7 d. He had a feeling of fatigue, constipation, foamy urine, poor appetite and sleep. He had a lacunar infarction for 5 years and hypertension for 9 mo. Laboratory results showed elevated eosinophils, cholesterol, uric acid, serum creatinine, urea and 24 h urine analysis revealed proteinuria. A renal biopsy revealed atheroembolic renal disease. Taken together, these findings strongly supported the diagnosis of idiopathic CCE and atheroembolic renal disease. CONCLUSION Atheroembolic renal disease and blue toes syndrome can be caused by idiopathic CCE, and early treatment with corticosteroids is effective but requires further investigation.

[1]  M. Kuwatani,et al.  Angiogenic Dreaded Killer: Cholesterol Crystal Embolization , 2020, Internal medicine.

[2]  H. Yasunaga,et al.  Proportion and risk factors of cholesterol crystal embolization after cardiovascular procedures: a retrospective national database study , 2020, Heart and Vessels.

[3]  A. Ozkok Cholesterol-embolization syndrome: current perspectives , 2019, Vascular health and risk management.

[4]  O. Abboud,et al.  Ciclosporin-induced accessory breast tissue: Dramatic improvement after dose adjustment. , 2019, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[5]  M. Tashiro,et al.  An autopsy case of idiopathic cholesterol embolism , 2013, Clinical and Experimental Nephrology.

[6]  I. Kronzon,et al.  Cholesterol embolization syndrome , 2011, Current opinion in cardiology.

[7]  K. Urabe,et al.  The Effect of Low-Dose Corticosteroids on Short- and Long-Term Renal Outcome in Patients with Cholesterol Crystal Embolism , 2011, Renal failure.

[8]  R. Ram,et al.  Cholesterol crystal embolization (CCE): Improvement of renal function with high-dose corticosteroid treatment. , 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[9]  L. Verneuil,et al.  Efficiency of colchicine and corticosteroids in a leg ulceration with cholesterol embolism in a woman with rheumatoid arthritis. , 2003, Rheumatology.

[10]  F. Scolari,et al.  Cholesterol crystal embolism: A recognizable cause of renal disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  D. Di Landro,et al.  A Possible Role of Corticosteroids in Cholesterol Crystal Embolization , 1999, Nephron.

[12]  M. Fine,et al.  Cholesterol Crystal Embolization: A Review of 221 Cases in the English Literature , 1987, Angiology.

[13]  Y. Iino,et al.  A patient with idiopathic cholesterol crystal embolization: effectiveness of early detection and treatment. , 2011, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.